Non-invasive longitudinal imaging of tumor progression using an (111)indium labeled CXCR4 peptide antagonist

The chemokine receptor 4 (CXCR4) is a biomarker that is over-expressed in ductal carcinoma in situ (DCIS). Hence, CXCR4-targeted (molecular) imaging approaches may have diagnostic value in such a challenging, premalignant lesion. The indium labeled CXCR4 peptide-antagonist, (111)In-DTPA-Ac-TZ14011,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Buckle, Tessa, van Berg, Nynke S, Kuil, Joeri, Bunschoten, Anton, Oldenburg, Joppe, Borowsky, Alexander D, Wesseling, Jelle, Masada, Ryo, Oishi, Shinya, Fujii, Nobutaka, van Leeuwen, Fijs WB
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: e-Century Publishing Corporation 2011
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3478110/
https://ncbi.nlm.nih.gov/pubmed/23133805
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller